Rhythm Pharmaceuticals, Inc. (RYTM) stock
RYTMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 5/30249% above fair value
$109.86−2.30 (-2.05%)
Close on Nov 12, 2026Market cap $7.56BP/E –Yield –
Rhythm Pharmaceuticals operating margin
Operating margin is operating income as a percentage of revenue.
Rhythm Pharmaceuticals's operating margin for the twelve months ending Jun 30, 2026 was -83.6%. For fiscal 2025 it was -101.2%, against -204.0% the year before. The highest annual figure on record is -101.2% in fiscal 2025.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -101.2% | +102.8 |
| FY2024 | Dec 31, 2024 | -204.0% | +34.1 |
| FY2023 | Dec 31, 2023 | -238.1% | +519.8 |
| FY2022 | Dec 31, 2022 | -757.9% | +4633.9 |
| FY2021 | Dec 31, 2021 | -5391.9% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -68.1% | +25.3 |
| Q1 FY2026 | Mar 31, 2026 | -87.1% | +56.6 |
| Q4 FY2025 | Dec 31, 2025 | -82.2% | +16.4 |
| Q3 FY2025 | Sep 30, 2025 | -102.6% | +29.3 |
| Q2 FY2025 | Jun 30, 2025 | -93.4% | +45.8 |
| Q1 FY2025 | Mar 31, 2025 | -143.7% | +395.0 |
| Q4 FY2024 | Dec 31, 2024 | -98.6% | +71.7 |
| Q3 FY2024 | Sep 30, 2024 | -132.0% | +63.3 |
| Q2 FY2024 | Jun 30, 2024 | -139.2% | +103.3 |
| Q1 FY2024 | Mar 31, 2024 | -538.7% | −80.7 |
| Q4 FY2023 | Dec 31, 2023 | -170.3% | +308.7 |
| Q3 FY2023 | Sep 30, 2023 | -195.3% | +721.3 |
| Q2 FY2023 | Jun 30, 2023 | -242.5% | +255.0 |
| Q1 FY2023 | Mar 31, 2023 | -458.0% | +3059.4 |
| Q4 FY2022 | Dec 31, 2022 | -479.0% | +2327.2 |
| Q3 FY2022 | Sep 30, 2022 | -916.6% | +3386.9 |
| Q2 FY2022 | Jun 30, 2022 | -497.4% | +14258.8 |
| Q1 FY2022 | Mar 31, 2022 | -3517.4% | +94762.6 |
| Q4 FY2021 | Dec 31, 2021 | -2806.2% | – |
| Q3 FY2021 | Sep 30, 2021 | -4303.5% | – |
| Q2 FY2021 | Jun 30, 2021 | -14756.2% | – |
| Q1 FY2021 | Mar 31, 2021 | -98280.0% | – |
See a number that looks wrong?